Abstract
Rabbit antiserum to lymphokine-containing supernatant fluids has been prepared by means of a two-stage immunization procedure. Migration inhibiting factor (MIF)-containing and control supernatants were obtained from guinea pig lymphocyte cultures. Both were fractionated on Sephadex G-100. Fractions of control supernatants corresponding to active fractions from the MIF-rich material were used to immunize rabbits. The anti-“control” antibody so obtained was conjugated to agarose beads to prepare an immunoadsorbent column. The MIF-rich Sephadex fractions were passed through this column to remove materials corresponding to those found in control supernatants and which could react with the anti-control antibody. The eluted MIF-rich fraction was concentrated and used to immunize a second group of rabbits. The anti-“lymphokine” antiserum so obtained was studied for its effect in vitro and in vivo. It was found capable of suppressing the activity of MIF, macrophage chemotactic factor, and skin reactive factor. It could also suppress delayed hypersensitivity skin reactions in actively immunized guinea pigs.
Footnotes
-
↵1 This work was supported by Grants AI-12225 and AI-12477 from the National Institutes of Health.
- Received August 26, 1974.
- Copyright © 1975 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.